Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BENADRYL
- Intravenous Fluids in Pediatric Migraine
- Intranasal Ketorolac Trial
- Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition
- Diphenhydramine and Sweating
- Trial of Diphenhydramine for Sleep in Children With Autism
- Geisinger Antibiotic Allergy Pilot Program: Assess and Address
- Coconut Oil to Prevent Mouth Sores in Pediatric Patients Receiving High Dose Chemotherapy
- Droperidol on Prevention of Cannabis Hyperemesis Syndrome
- Using Doxepin for Urticaria
- HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
- TReatment for ImmUne Mediated PathopHysiology
- Intraoperative Imaging of Pulmonary Nodules by SGM-101
- Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
- Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel
- Stem Cell Transplantation in Crohn's Disease
- C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
- Everolimus Monotherapy as Immunosuppression After Liver Transplant
- Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine
- Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
- Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia
- CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
- Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
- Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma
- C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
- A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache
- Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
- GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
- Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
- Intravenous Fluids in Benign Headaches Trail
- Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer
- Minimal Opioid Use After Total Hip Replacement (THR)
- Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
- "THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"
- A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
- Metoclopramide for Post-Traumatic Headache. A Pilot Study
- Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department
- Trial of Isatuximab (SAR650984) in Patients With Intermediate and High Risk Smoldering Multiple Myeloma
- Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
- CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
- Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study
- Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers
- Treg Therapy in Subclinical Inflammation in Kidney Transplantation
- Auricular Acupuncture vs SOC in Migraine HA
- The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
- An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers
- Altitude Sickness Prevention and Efficacy of Comparative Treatments
- Trial of Immune Reconstitution With Activated T-Cells Following Lymphodepleting Chemotherapy in Patients With Chronic Lymphocytic Leukemia (CLL)
- Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
- Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting
- Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
- Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine
- A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective.
- Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease
- A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
- Histamine Glutamate Antagonism in Stroke
- Safety Study of TPI-287 to Treat CBS and PSP
- Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
- Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial
- Psilocybin-facilitated Treatment for Cocaine Use
- BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
- Multicenter Pilot Phase III Clinical Trials of JDP-205 iv Injection for the Treatment of Acute Urticaria Associated With an Acute Allergic Reaction.
- Anti-histamines and Methacholine Challenges.
- Effects of Intravenous Lidocaine on Endometriosis Pain
- Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids
- A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease
- iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
- Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma
- Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
- Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
- Diphenhydramine for Acute Migraine
- Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
- The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin
- Comparison of Wound Bed Establishment in Facial Burns
- CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)
- CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
- Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
- Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
- Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
- TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer
- Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
- Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
- SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
- Open-Label Study of TPI 287 for Patients With Metastatic Melanoma
- TPI 287 in Breast Cancer Metastatic to the Brain
- Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury
- To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy
- Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
- Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
- Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
- Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
- Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)
- TPI 287 in Patients With Recurrent Glioblastoma Multiforme
- Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)
- Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
- A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
- Study on the Development of Opioid Induced Hyperalgesia (OIH) After Exposure to Alfentanil
- Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
- CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies
- Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome
- Chicago Social Drinking Project
- Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
- Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
- Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
- Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma
- Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
- Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer
- Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
- Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
- Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
- Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children
- Alemtuzumab + Rituximab Consolidation in CLL
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
- Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
- Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
- Sodium Stibogluconate Treatment of Leishmaniasis
- Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
- Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
- Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia
- Non-Myeloablative Allogeneic Stem Cell Transplantation
- CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Papillary Serous Carcinoma of the Endometrium
- Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
- Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas
- Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
- Phase 2 Study of Bexxar in Relapsed/Refractory DLCL
- Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT
- Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
- Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
- FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia
- Ph II CHOP+Velcade in Mediastinal LBCL
- Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
- Preop Chemoradiation Resectable Pancreas
- Nalbuphine for the Treatment of Opioid Induced Pruritus in Children
- Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
- Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy
- FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years
- Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
- Effect of Benadryl Sedation During ERCP or EUS
- A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
- Treatment of Orthostatic Hypotension in Autonomic Failure
- Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury
- Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
- Allogeneic Transplantation From Related Haploidentical Donors
- CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia
- Post Burn Pruritus Study in Patients Undergoing Wound Healing
- Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
- Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma
- Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
- Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation
- Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
- Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
- Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
- Safety and Efficacy of Campath in Nonmyeloablative Transplantation
- Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
- Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
- BMS 247550 to Treat Kidney Cancer
- Topiramate in the Treatment of Sciatica
Clinical trials list
click for details